Dupilumab in Severe Asthma: A Real-Life Cohort in France

被引:0
|
作者
Dupin, C. [1 ,2 ]
Guilleminault, L. [3 ]
Bonniaud, P. [4 ]
Gamez, A. [5 ]
Leroyer, C. [6 ]
Mahay, G. [7 ]
De Blay, F. [8 ]
Fry, S. [9 ]
Le Bourdelles, G. [10 ]
Proust, A. [11 ]
Rosencher, L. [12 ]
Belhadi, D. [13 ]
Berger, P. [14 ]
Dider, A. [3 ]
Bourdin, A. [15 ]
Chenivesse, C. [9 ]
Garcia, G. [16 ]
Couffignal, C. [13 ]
Taille, C. [1 ,2 ]
机构
[1] Hop Bichat Claude Bernard, Serv Pneumol, Paris, France
[2] Hop Bichat Claude Bernard, Ctr Reference Constitutif Malad Pulm Rares, Paris, France
[3] Hop Larrey, Pole Voies Resp, Toulouse, France
[4] CHU Bourgogne, Serv Pneumol & Soins Intens Resp, Dijon, France
[5] CHU Montpellier, De & 769 Partement Pneumol & Addictol, Ho & 770 Pital Arnaud de Villeneuve, Montpellier, France
[6] Hop La Cavale Blanche, Dept Med Interne & Pneumol, Brest, France
[7] CHU Rouen, Serv Pneumol Oncol Thorac & Soins Intens Resp Pne, Rouen, France
[8] CHU Strasbourg, Dept Pathol Thorac, Strasbourg, France
[9] CHU Lille, Serv Pneumol & Immunoallergol, Lille, France
[10] Hop Foch, Serv Pneumol, Suresnes, France
[11] CHU Nimes, Serv Pneumol, Npimes, France
[12] Hop Tenon, Sdept Pneumol & Reanimat Resp, Unite Fonct Oncol Thorac, Paris, France
[13] Hop Bichat Claude Bernard, Unite Rech Clin, Paris, France
[14] CHU Bordeaux, Serv Pneumol, Bordeaux, France
[15] CHU Montpellier, Ho & 770 Pital Arnaud de Villeneuve, De & 769 Partement Pneumol & Addictol, Paris, France
[16] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1267
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
    Israel, Elliot
    Canonica, Giorgio Walter
    Brusselle, Guy
    Yang, Shibing
    Howarth, Peter H.
    Martin, Amber L.
    Koufopoulou, Maria
    Smith, Steven G.
    Alfonso-Cristancho, Rafael
    JOURNAL OF ASTHMA, 2022, 59 (11) : 2201 - 2217
  • [42] Severe asthma and long-term Benralizumab effectiveness in real-life
    Sposato, B.
    Scalese, M.
    Camiciottoli, G.
    Carpagnano, G. E.
    Pelaia, C.
    Santus, P.
    Pelaia, G.
    Palmiero, G.
    Di Tomassi, M.
    Ronchi, M. C.
    Cameli, P.
    Bargagli, E.
    Ciambellotti, L.
    Rizzello, S.
    Sglavo, R.
    Coppola, A.
    Lacerenza, L. G.
    Gabriele, M.
    Radovanovic, D.
    Perrella, A.
    Ricci, A.
    Rogliani, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (20) : 7461 - 7473
  • [43] Saudi Arabian real-life experience with biologic therapy in severe asthma
    Eldaboussi, Safwat
    Qabil, Ahmed
    Lotfi, Ahmed
    Awad, Amgad
    Salam, Eman Abdel
    Alkhamis, Abdullah
    Abuelhassan, Usama E.
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2021, 16
  • [44] Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study
    da Costa Martins, Sara Maria
    Tinoco, Eduarda
    Cabrita, Bruno
    Machado, Daniela
    Franco, Ines
    Ladeira, Ines
    Pascoal, Ivone
    Lima, Ricardo
    Valente, Salete
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [45] The level of diagnostic assessment in severe asthma: A nationwide real-life study
    von Bulow, Anna
    Backer, Vibeke
    Bodtger, Uffe
    Soes-Petersen, Niels Ulrik
    Assing, Karin Dahl
    Skjold, Tina
    Porsbjerg, Celeste
    RESPIRATORY MEDICINE, 2017, 124 : 21 - 29
  • [46] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    Padilla-Galo, A.
    Garcia-Ruiz, A. J.
    Levy Abitbol, R. Ch.
    Olveira, C.
    Rivas-Ruiz, F.
    Garcia-Agua Soler, N.
    Perez Morales, M.
    Valencia Azcona, B.
    Tortajada-Goitia, B.
    Moya-Carmona, I.
    Levy-Naon, A.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [47] Real-life Cretan asthma registry focused on severe asthma: On behalf of 'The Cretan registry of the use of Biologics in Severe Asthma'
    Antoniou, Katerina M.
    Bolaki, Maria
    Karagiannis, Konstantinos
    Trachalaki, Athina
    Ierodiakonou, Despo
    Stamatopoulou, Vagia
    Chatzinikolaou, Charito
    Mastrodimou, Semeli
    Stamataki, Evangelia
    Pitsidianakis, George
    Lambiri, Irini
    Mitrouska, Ioanna
    Spandidos, Demetrios A.
    Tzanakis, Nikolaos
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
  • [48] Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
    Pelaia, Corrado
    Benfante, Alida
    Busceti, Maria Teresa
    Caiaffa, Maria Filomena
    Campisi, Raffaele
    Carpagnano, Giovanna Elisiana
    Crimi, Nunzio
    D'Amato, Maria
    Barbaro, Maria Pia Foschino
    Maglio, Angelantonio
    Minenna, Elena
    Nolasco, Santi
    Paglino, Giuseppe
    Papia, Francesco
    Pelaia, Girolamo
    Portacci, Andrea
    Ricciardi, Luisa
    Scichilone, Nicola
    Scioscia, Giulia
    Triggiani, Massimo
    Valenti, Giuseppe
    Vatrella, Alessandro
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
    Pelaia, Corrado
    Benfante, Alida
    Busceti, Maria Teresa
    Caiaffa, Maria Filomena
    Campisi, Raffaele
    Carpagnano, Giovanna Elisiana
    Crimi, Nunzio
    D'Amato, Maria
    Barbaro, Maria Pia Foschino
    Maglio, Angelantonio
    Minenna, Elena
    Nolasco, Santi
    Paglino, Giuseppe
    Papia, Francesco
    Pelaia, Girolamo
    Portacci, Andrea
    Ricciardi, Luisa
    Scichilone, Nicola
    Scioscia, Giulia
    Triggiani, Massimo
    Valenti, Giuseppe
    Vatrella, Alessandro
    Crimi, Claudia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [50] Dupilumab in the Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma-A Multidisciplinary Monocentric Real-Life Study
    Fadda, Gian Luca
    Rustichelli, Chiara
    Soccal, Simone
    Moglio, Simone
    Serrone, Alessandro
    Bertolini, Francesca
    Carriero, Vitina
    Pizzimenti, Stefano
    Levra, Stefano
    Cavallo, Giovanni
    Ricciardolo, Fabio Luigi Massimo
    Guida, Giuseppe
    BIOMEDICINES, 2025, 13 (02)